Abstract |
The pain experienced after third molar surgery was used as a model to evaluate the analgesic efficacy of a new non-steroidal anti-inflammatory drug, lornoxicam, in a Phase II study. One hundred and fifty fit, young adults participated in this randomised, single dose, double-blind, parallel group clinical study. Three doses of lornoxicam (2 mg, 4 mg, and 8 mg) were compared with aspirin 650 mg and placebo. Patients suffering from moderate to severe pain following surgery were monitored for up to 8 hours. All indices of efficacy showed similar results, all active treatments being associated with highly significant (P less than 0.0001) reductions in pain during the study period. Lornoxicam 8 mg demonstrated significant analgesic efficacy as compared with placebo. The two lower doses of lornoxicam and aspirin all showed apparent degrees of efficacy intermediate between that of placebo and lornoxicam 8 mg, although the trial proved to have inadequate power to show significant differences between these three treatments. Lornoxicam was very well tolerated at all three doses studied, with no adverse events definitely attributable to its administration.
|
Authors | A Patel, A M Skelly, H Kohn, H W Preiskel |
Journal | British dental journal
(Br Dent J)
Vol. 170
Issue 8
Pg. 295-9
(Apr 20 1991)
ISSN: 0007-0610 [Print] England |
PMID | 2036277
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Piroxicam
- lornoxicam
- Aspirin
|
Topics |
- Adolescent
- Adult
- Analysis of Variance
- Anti-Inflammatory Agents, Non-Steroidal
(administration & dosage)
- Aspirin
(administration & dosage)
- Chi-Square Distribution
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Molar, Third
(surgery)
- Pain Measurement
- Pain, Postoperative
(drug therapy)
- Piroxicam
(administration & dosage, analogs & derivatives)
- Tooth Extraction
|